|
On April 26, 2007 GeneraMedix Inc. received
approval from the U.S. Food and Drug Administration (FDA)
for its Abbreviated New Drug Applications (ANDAs) for Fluorouracil
Injection, USP. GeneraMedix will market Fluorouracil 50
mg/mL in 10 mL, 20 mL, 50 mL and 100 mL vials. The product
is AP rated and equivalent to the reference listed drugs
of Abraxis Pharmaceutical Products and Sicor Pharmaceuticals,
Inc.
For product information please contact:
GeneraMedix Inc. Customer Service
1-866–GENERA–1
(1-866-436-3721)
|
